Ilaria Pesci

Pr
Fidenza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 04, 2026

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Journal: JAMA network open

Published: November 03, 2025

Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study).

Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study).

Journal: Journal of neurology

Published: July 16, 2025

Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.

Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.

Journal: Journal of neurology

Published: September 04, 2024

Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA).

Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA).

Journal: Journal of neurology

Published: June 12, 2024

Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study.

Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study.

Journal: Multiple sclerosis and related disorders

Published: June 09, 2024

Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.

Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.

Journal: Journal of neurology

Published: March 25, 2024

Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.

Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: March 08, 2024

Multiple Sclerosis Progression and Relapse Activity in Children.

Multiple Sclerosis Progression and Relapse Activity in Children.

Journal: JAMA neurology

Published: November 27, 2023

Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.

Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.

Journal: Journal of neurology

Published: September 25, 2023

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.

Journal: Journal of neurology

Published: August 08, 2023

Sars-CoV2 infection in pregnant women with multiple sclerosis.

Sars-CoV2 infection in pregnant women with multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 26, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026